Full-Time

Associate Director

Incentive Compensation

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$148k - $184.5kAnnually

+ Discretionary Bonus + Equity Awards

Senior, Expert

Princeton, NJ, USA + 1 more

More locations: San Diego, CA, USA

This position requires in-office work three days per week on average.

Category
Customer Success Management
Sales & Account Management
Required Skills
Customer Service
Data Analysis
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

You match the following Acadia Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in business administration, marketing, finance or related field; MS/MBA highly desirable.
  • Targeting 8+ years’ experience in the pharmaceutical industry in a variety of progressively responsible Sales & Marketing positions including 5+ years in Commercial or Sales Operations with at least 4 years’ experience in field-based incentive compensation plan development and/or administration.
  • Prior experience planning and managing sales incentive compensation plans, contests and award programs.
  • Well versed in field incentive compensation plan design, goaling methodologies, processes, and techniques.
  • Demonstrated success to work cross functionally in achieving approvals and deadlines for communicating IC plans, goals and payouts.
  • Experience in establishing and administer governance and robust quality control processes.
  • Highly proficient with MS excel and PowerPoint.
  • Ability to think critically and form a methodical analytic approach to solving business problems.
  • Well organized with a successful record of creating and managing complex project plans, timelines, budgets, and critical paths.
  • Strong ability to multitask, prioritize, delegate, and manage shifting strategies, tactics, and responsibilities in a dynamic, cross-functional teamwork environment.
  • Experience working with biotech/pharmaceutical commercial physician/patient/payer data (HUB, SP, RX, Claims), commercial data warehouse concepts, and PowerBI reporting tools (and/or similar analytics reporting platforms).
  • Strong interpersonal skills with excellent verbal and written communication abilities.
  • Excellent diplomacy and facilitation skills; ability to influence without authority, skilled at negotiating with business partners or management and influencing senior level leaders.
  • Demonstrated on-stage presence and presentation skills with the ability to communicate complex concepts and ideas to leadership and the sales force in a easy to understand and relatable terms.
  • Strong sense of customer service and care towards internal stakeholders, with success in communicating, understanding and supporting field team needs.
  • Insightful understanding of the regulatory, legal and compliance requirements for incentive compensation (bonus), and pharmaceutical sales/marketing.
  • Proficient at creating and communicating a clear vision among team members effectively aligning resources and activities to achieve functional area and/or organizational goals.
Responsibilities
  • Lead and administer the field incentive compensation, contest/award functional area for the US field teams that are motivating, rewarding, and aligns with business objectives by collaborating with internal stakeholder and vendors:
  • Lead the evaluation, development, design and administer IC Plans, contests, and annual awards for the Neuroscience Field teams, national account group, along with their field management teams.
  • Provide leadership around governance, and approval process for IC plans, contests, and awards.
  • Implement strategies and administrative processes to ensure accurate goal setting, crediting, performance, and payout calculations.
  • Develop, deploy and administer routine reports/dashboards/scorecards that allows individual field team members and internal leaders to track their performance as it relates to their IC, contests/SPIFFs and awards.
  • Perform routine “Health-Check” and analysis on the individual IC plans, contests and awards to ensure that the plan performance is meeting the overall goals and objectives.
  • Lead the field Incentive Comp inquiring and investigation process, to track inbound requests, quickly research, and communicate back the findings/outcomes from the investigations.
  • Ensure timely communication and documentation to the field teams around IC/contest/award plans, sales goals/quotas, performance status reports(dashboards), and the administration processes.
  • Collaborate with the IT, Data Governance groups, and outside vendors to ensure master data used for IC is accurate, that there is efficient integration between IC Platforms & the rest of the commercial data systems to provide accurate, efficient, and reliable “IC Grade” data for incentive compensation calculations and reports/scorecards.
  • Work with Commercial Analytics setting field sales quotas to ensure alignment with topline forecast/Latest Estimates.
  • Act as a key point of contact for Commercial field team,s including Sales Leadership.
  • Other responsibilities as assigned.
Desired Qualifications
  • High-energy, detail-oriented, and self-motivated individual.
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, which are then approved by regulatory bodies like the FDA before being sold to patients and healthcare providers. What sets Acadia apart from competitors is its long-standing commitment to addressing unmet medical needs in neuroscience, along with its emphasis on corporate social responsibility, including diversity and inclusion. The goal of Acadia Pharmaceuticals is to improve the quality of life for individuals suffering from challenging neurological diseases through effective treatments.

Company Size

501-1,000

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's recent Health Canada approval for Daybue boosts its market presence in Canada.
  • The exclusive license agreement with Saniona expands Acadia's drug portfolio with SAN711.
  • Hiring Thomas Andrew Garner as CCO strengthens Acadia's commercial leadership team.

What critics are saying

  • Increased competition in CNS drugs may impact Acadia's market share and growth.
  • Regulatory challenges could delay or prevent new drug approvals, affecting revenue.
  • High drug development costs may strain financial resources if trials are unsuccessful.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neurological disorders like Parkinson's and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia collaborates with partners like Biovail to enhance drug development and commercialization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Company News

Fierce Pharma
Dec 9th, 2024
Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead

Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO).

MarketWatch
Nov 26th, 2024
Acadia Pharmaceuticals in Exclusive License Agreement With Saniona for SAN711

Acadia Pharmaceuticals on Tuesday said it entered into an exclusive worldwide license agreement with Saniona to develop and commercialize SAN711.

World Pharmaceuticals
Oct 17th, 2024
Acadia gets Health Canada approval for Daybue to treat Rett Syndrome

US-based biopharmaceutical company Acadia Pharmaceuticals has received Health Canada marketing authorisation for Daybue (trofinetide) to treat a rare genetic neurological disorder.

PRWeb
Aug 23rd, 2024
Global Genes' Annual Week In Rare Event Heading To Kansas City

"Week in RARE provides advocates a unique opportunity to participate in multiple events in one place to maximize their time, travel, and potential to gain benefits from their participation."

Yahoo Finance
Aug 15th, 2024
Ryan Reynolds Announces More To Parkinson'S(R) Campaign

Ryan & Tammy Reynolds (Photo: Business Wire)Acadia Parkinson's Fact Sheet-- The national disease awareness campaign aims to educate and drive conversation about recognizing and managing non-motor symptoms of Parkinson’s, including hallucinations and delusions-- Reynolds and his mother Tammy share their personal story about the impact of these symptoms on their familySAN DIEGO, August 14, 2024--(BUSINESS WIRE)--Ryan Reynolds, a world-renowned actor/entrepreneur and Parkinson’s disease advocate, with Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of a multi-faceted disease education campaign, More to Parkinson’s®, to raise awareness among caregivers, patients and their care providers about a common, yet under-recognized aspect of Parkinson’s disease – Parkinson’s-related hallucinations and delusions.Notably, around half of the people living with Parkinson’s disease may develop hallucinations or delusions over the course of their disease, but up to 90% of people currently do not proactively tell their physicians about these symptoms.1-3 By sharing their experiences caring for Ryan’s father, James "Jim" Reynolds, who passed away nearly a decade ago, Ryan and his mother Tammy, aim to raise awareness, educate and drive conversation between people with Parkinson’s disease, their families and their doctors about how best to talk about and treat these non-motor symptoms."My father experienced hallucinations and delusions. At the time, we didn’t know any of these types of symptoms were part of his Parkinson’s disease," Reynolds explains. "Like a lot of caregivers, my mom mostly tried to carry these burdens alone. I wish I’d known Parkinson’s disease wasn’t limited to only motor symptoms. I think people and families affected by Parkinson’s can be better prepared to manage hallucinations and delusions if they’re talking early and often about this lesser-known aspect of the disease."This press release features multimedia